Diese Seite wurde automatisch übersetzt und die Genauigkeit der Übersetzung wird nicht garantiert. Bitte wende dich an die englische Version für einen Quelltext.

Effects of a 12-week T10 Exercise Program on Shooting Performance, Upper Extremity Function, Balance and Reaction Time in Competitive Air Pistol Athletes (Air pistol T10)

26. Juni 2026 aktualisiert von: Nazli Cigercioglu, Hacettepe University

The Effects of a 12-Week T10 Exercise Program on Shooting Performance, Upper Extremity Function, Balance, and Reaction Time in Air Pistol Athletes: A Randomized Controlled Trial

Air pistol shooting requires a high level of postural stability, upper extremity neuromuscular control, and concentration to achieve optimal performance. Prolonged maintenance of the shooting position may lead to shoulder muscle fatigue, reduced joint stability, and impaired shooting accuracy. Although sport-specific exercise programs have been recommended to improve physical performance in shooters, the effectiveness of the T10 exercise program has not yet been investigated in this population. This randomized controlled trial aims to evaluate the effects of a 12-week T10 exercise program, in addition to routine training, on shooting performance in competitive air pistol athletes. Secondary outcomes include upper and lower extremity functional performance, balance, muscular endurance, upper extremity stability, grip strength, medicine ball throw performance, and visual and auditory reaction time. Participants will be randomly allocated to either an intervention group receiving the T10 exercise program plus routine training or a control group continuing routine training alone. Assessments will be performed at baseline and after the 12-week intervention. The findings of this study may provide evidence for the effectiveness of a sport-specific neuromuscular exercise program in enhancing shooting performance and physical function in competitive air pistol athletes.

Studienübersicht

Status

Noch keine Rekrutierung

Detaillierte Beschreibung

Air pistol shooting is a precision sport that requires a high level of postural stability, upper extremity neuromuscular control, and sustained concentration to achieve accurate shooting performance. During competition, athletes maintain the shoulder in an elevated position for prolonged periods, which may result in muscle fatigue, impaired scapular stability, altered shoulder mechanics, and reduced shooting accuracy. In addition, deficiencies in balance, upper extremity stability, muscular endurance, and reaction time may negatively influence shooting performance.

Previous studies have suggested that physical conditioning and sport-specific exercise programs may improve athletic performance in shooting sports. The T10 exercise program is a comprehensive upper extremity training protocol consisting of ten exercises designed to improve neuromuscular control, dynamic stabilization, co-contraction, muscle strength, endurance, coordination, and movement quality. Despite its potential benefits, the effectiveness of the T10 exercise program has not been investigated in competitive air pistol athletes.

The primary objective of this randomized controlled trial is to determine the effects of a 12-week T10 exercise program on shooting performance in competitive air pistol athletes. Secondary objectives are to evaluate the effects of the intervention on upper extremity functional performance, upper extremity stability, dynamic balance, static balance, muscular endurance, grip strength, medicine ball throw performance, agility, lower extremity explosive performance, and visual and auditory reaction time.

A minimum of 24 competitive air pistol athletes aged 18 to 40 years will be recruited and randomly allocated to either an intervention group or a control group using simple randomization. Participants in the intervention group will perform the T10 exercise program three times per week for 12 weeks in addition to their routine shooting training, whereas participants in the control group will continue their routine training without additional exercises.

Outcome assessments will be performed at baseline and after the 12-week intervention. The primary outcome will be shooting performance. Secondary outcomes will include Upper Quarter Y Balance Test, Y Balance Test, Flamingo Balance Test, grip strength, medicine ball throw test, Closed Kinetic Chain Upper Extremity Stability Test, push-up and sit-up performance, T-test, standing long jump, and visual and auditory reaction time. The findings of this study are expected to provide evidence regarding the effectiveness of a sport-specific neuromuscular exercise program for improving shooting performance and physical function in competitive air pistol athletes and may contribute to the development of evidence-based training strategies for precision shooting sports.

Studientyp

Interventionell

Einschreibung (Geschätzt)

24

Phase

  • Unzutreffend

Kontakte und Standorte

Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.

Studienkontakt

Studienorte

Teilnahmekriterien

Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.

Zulassungskriterien

Studienberechtigtes Alter

  • Erwachsene

Akzeptiert gesunde Freiwillige

Ja

Beschreibung

Inclusion Criteria:

  • Age between 18 and 40 years.
  • Competitive air pistol athletes with at least 2 years of regular shooting experience.
  • Participating in shooting training for at least 6 hours per week.
  • Being in the preseason training period.
  • Willing to participate and able to provide written informed consent.

Exclusion Criteria:

  • Current upper extremity musculoskeletal injury or pain.
  • History of upper extremity orthopedic surgery.
  • Neurological or cognitive disorders affecting participation.
  • Visual or hearing impairments that may interfere with testing or shooting performance.
  • Inflammatory joint disease involving the lower extremities.
  • History of lower extremity orthopedic surgery or musculoskeletal deformity affecting performance.
  • Rheumatologic, metabolic, or cardiovascular disease.
  • Body mass index (BMI) >30 kg/m².
  • Current use of psychiatric medication.
  • Failure to attend two consecutive intervention sessions during the study period.

Studienplan

Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.

Wie ist die Studie aufgebaut?

Designdetails

  • Hauptzweck: Behandlung
  • Zuteilung: Zufällig
  • Interventionsmodell: Parallele Zuordnung
  • Maskierung: Keine (Offenes Etikett)

Waffen und Interventionen

Teilnehmergruppe / Arm
Intervention / Behandlung
Experimental: Intervention Group
Participants will receive the T10 exercise program three times per week for 12 weeks in addition to their routine shooting training.
Participants in the control group will continue their regular shooting training throughout the 12-week study period without receiving the T10 exercise program or any additional physiotherapist-supervised exercise intervention. Routine training will be conducted according to the athletes' usual training schedule under the supervision of their shooting coaches and will include technical shooting practice, aiming exercises, competition-specific drills, and standard warm-up activities. Participants will be instructed to maintain their usual training habits and refrain from initiating any additional upper extremity strengthening or neuromuscular exercise programs during the study period.
Experimental: Control Group
Participants will continue their routine shooting training without any additional exercise intervention.
Participants in the control group will continue their regular shooting training throughout the 12-week study period without receiving the T10 exercise program or any additional physiotherapist-supervised exercise intervention. Routine training will be conducted according to the athletes' usual training schedule under the supervision of their shooting coaches and will include technical shooting practice, aiming exercises, competition-specific drills, and standard warm-up activities. Participants will be instructed to maintain their usual training habits and refrain from initiating any additional upper extremity strengthening or neuromuscular exercise programs during the study period.
Andere Namen:
  • routine shooting training

Was misst die Studie?

Primäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Shooting Performance Score
Zeitfenster: Baseline and 12 weeks
Shooting performance will be assessed according to the official International Shooting Sport Federation (ISSF) rules using the athletes' total shooting score obtained during a standardized air pistol shooting test. Higher scores indicate better shooting performance.
Baseline and 12 weeks

Sekundäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
1. Upper Quarter Y Balance Test
Zeitfenster: Baseline and 12 weeks
Upper extremity dynamic balance and stability will be assessed using the Upper Quarter Y Balance Test. Reach distances in the medial, superolateral, and inferolateral directions will be recorded and normalized to upper limb length.
Baseline and 12 weeks
2. Y Balance Test
Zeitfenster: Baseline and 12 weeks
Dynamic balance of the lower extremity will be evaluated using the Y Balance Test. Reach distances in the anterior, posteromedial, and posterolateral directions will be recorded and normalized to leg length.
Baseline and 12 weeks
3. Flamingo Balance Test
Zeitfenster: Baseline and 12 weeks
Static balance performance will be assessed by recording the duration participants maintain balance on a narrow beam.
Baseline and 12 weeks
4. Grip Strength
Zeitfenster: Baseline and 12 weeks
Maximal isometric handgrip strength will be measured using a Jamar hand dynamometer. The mean of three trials will be recorded in kilograms (kg).
Baseline and 12 weeks
5. Medicine Ball Throw Test
Zeitfenster: Baseline and 12 weeks
Upper extremity explosive performance will be evaluated using a 3-kg medicine ball throw. Throwing distance will be recorded in centimeters (cm).
Baseline and 12 weeks
6. Closed Kinetic Chain Upper Extremity Stability Test (CKCUEST)
Zeitfenster: Baseline and 12 weeks
Upper extremity stability and functional performance will be assessed using the number of touches completed within 15 seconds.
Baseline and 12 weeks
7. Push-up Test
Zeitfenster: Baseline and 12 weeks
Upper extremity muscular endurance will be assessed by recording the maximum number of push-ups completed within one minute.
Baseline and 12 weeks
8. Sit-up Test
Zeitfenster: Baseline and 12 weeks
Core muscular endurance will be assessed by recording the maximum number of sit-ups completed within one minute.
Baseline and 12 weeks
9. T-Test
Zeitfenster: Baseline and 12 weeks
Agility performance will be assessed using the T-Test, with completion time recorded in seconds. Lower values indicate better agility performance.
Baseline and 12 weeks
10. Standing Long Jump Test
Zeitfenster: Baseline and 12 weeks
Lower extremity explosive power will be evaluated by measuring jump distance in centimeters (cm).
Baseline and 12 weeks
11. Visual Reaction Time
Zeitfenster: Baseline and 12 weeks
Visual reaction time will be measured using the Newtest 1000 reaction timer. The average response time will be recorded in milliseconds (ms).
Baseline and 12 weeks
12. Auditory Reaction TimeAuditory
Zeitfenster: Baseline and 12 weeks
reaction time will be measured using the Newtest 1000 reaction timer. The average response time will be recorded in milliseconds (ms).
Baseline and 12 weeks
13. Ruler Drop Test
Zeitfenster: Baseline and 12 weeks
Reaction time will also be assessed using the ruler drop test. The catching distance will be recorded in centimeters (cm).
Baseline and 12 weeks

Mitarbeiter und Ermittler

Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.

Publikationen und hilfreiche Links

Die Bereitstellung dieser Publikationen erfolgt freiwillig durch die für die Eingabe von Informationen über die Studie verantwortliche Person. Diese können sich auf alles beziehen, was mit dem Studium zu tun hat.

Studienaufzeichnungsdaten

Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.

Haupttermine studieren

Studienbeginn (Geschätzt)

10. Juli 2026

Primärer Abschluss (Geschätzt)

15. November 2026

Studienabschluss (Geschätzt)

15. Dezember 2027

Studienanmeldedaten

Zuerst eingereicht

26. Juni 2026

Zuerst eingereicht, das die QC-Kriterien erfüllt hat

26. Juni 2026

Zuerst gepostet (Tatsächlich)

2. Juli 2026

Studienaufzeichnungsaktualisierungen

Letztes Update gepostet (Tatsächlich)

2. Juli 2026

Letztes eingereichtes Update, das die QC-Kriterien erfüllt

26. Juni 2026

Zuletzt verifiziert

1. Juni 2026

Mehr Informationen

Begriffe im Zusammenhang mit dieser Studie

Plan für individuelle Teilnehmerdaten (IPD)

Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?

NEIN

Beschreibung des IPD-Plans

Individual participant data (IPD) will not be made publicly available because the study includes a small sample size of competitive athletes, which may increase the risk of participant identification despite de-identification. Only aggregate, anonymized study results will be reported in publications and presentations.

Arzneimittel- und Geräteinformationen, Studienunterlagen

Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt

Nein

Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt

Nein

Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .

Abonnieren